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Abstract
Background: The analysis of vascular access for haemodialysis is 
relevant for the quality of life of patient. In this study we investigated 
the profile of vascular access used for haemodialysis patients in a poor 
place, interior of Brazil.
Objectives: To identify the percentage of vascular access for hae-
modialysis in this unit conforms to international standards.
Methods: We evaluated the reference haemodialysis service in a spe-
cific poor place in Brazil. There are 120 patients of both genders who 
have undergone implant or manufacture of vascular haemodialysis 
access; there aren´t patients on renal replacement therapy by perito-
neal dialysis.
Results: Associated diseases were unknown cause, diabetes mellitus 
and hypertension. 93 (77.5%) had arteriovenous fistula, with 89 held 
by the same dialysis and four of them were still maturing. 27 patients 
on dialysis used central venous catheter. 91 were native and two 
were made using polytetrafluoroethylene prosthesis (PTFE). Among 
the 27 patients with central venous catheters, twenty were short-
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Background
The need for a vascular access is essential for effec-
tive maintenance dialysis [1]. The arteriovenous fistu-
la (AVF) are widely recommended to offers higher 
patency rates, lower mortality and morbidity, and 
lower costs compared with central venous cathe-
ters or arteriovenous grafts. [2-4]. An ideal access 
delivers a flow rate adequate for the dialysis pres-
cription, has a long use-life, and has a low rate 
of complications (infection, stenosis, thrombosis, 
aneurysm, and limb ischemia). 
Compared with the general population, dialy-
sis patients have a 100-fold greater risk of sepsis-
related death, with infection-related and all-cause 
mortality highest with catheters. [5] Use of Central 
Venous Catheters for haemodialysis has increased 
in recent years, comprising approximately 25% of 
prevalent haemodialysis patients in the United Sta-
tes [6, 7]. Long-term dialysis using tunneled, cuffed 
catheters increases a patients risk of death 2- to 
3-fold and serious infection 5- to 10-fold compa-
red with dialysis using AVF. [8].
Because of this, the National Vascular Access Im-
provement Initiative-Fistula First has set a goal of 
66% fistula prevalence in haemodialysis patients by 
June 2009. [3, 9] They should be made 6 months 
prior to initiating haemodialysis. [10] If an AVF can-
not be created, an AVF graft or venous catheter 
may be needed [11, 12] but they should be avoided 
[6, 13]. The studies showed that the native access 
presents the best patency (4 to 5 years) and lower 
rate of reoperation when compared with other ac-
cesses [14, 15].
The analysis of frequent dialysis services is im-
portant for improving patient care essential aiming 
adequacy in relation to recommended guidelines 
and also to improvements of vascular. The moni-
toring the quality of service and maintain control 
over the goals are advocated by THE NATIONAL 
KIDNEY FOUNDATION KIDNEY DISEASE OUTCO-
MES QUALITY INITIATIVE (NKF KDOQI™) Clinical 
Practice Guidelines [16, 17]. Thus, this analysis tries 
available the adequacy of the haemodialysis service 
with the guidelines.
term catheter and 7 were long-term catheter. Among the fistulas for 
dialysis patients, the highest prevalence was radiocephalic fistula in 
60 patients (50%).
Among all the fistulas, the left radiocephalic was the most found, 
in 37 patients (39.8%) and right, in 23 patients (24.7%). The number 
of patients that they had only one fistula manufactured corresponded 
60 patients (50%) and mean duration of use was 1,74 ±1,64 years, 
ranging from two months to 9 years.
Conclusion: Our unit of haemodialysis is above the limits established 
by international norms.
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Method
Population
This is a descriptive transversal observational study 
conducted on January 2013. We performed the stu-
dy on the dialysis unit, Juazeiro Nephrology Center 
(CNJ), in a pour area in Brazil, in a reference dialysis 
unit located in the largest city in the interior of Cea-
rá. The sample consisted of 120 patients (77 males). 
The study was approved by the Ethics Committee 
of the ABC Medicine College, with questionnaires 
and physical examination in all patients on dialysis. 
All patients gave informed consent. All procedures 
were in compliance with the Helsinki Declaration.
Inclusion and exclusion criteria
We included all patients, which were in agreement 
with the consent term, who have undergone implant 
or manufacture of haemodialysis vascular access.
Variables
We evaluated the following variables: gender, age, 
time which the subject was using haemodialysis, 
financing, cause, co-infection by hepatitis and HIV 
virus, actual and previous access.
Statistical Analysis
For the descriptive statistics we used the Microsoft 
Excel® program.
Results 
Data from 120 patients were analyzed on January 
2013, this represented, 100 % of patients in the 
Nephrology Center of Juazeiro-CE, reference dialysis 
clinic in the poor area in the Country Brazil that it 
was five years old. 
The most prevalent sex was male in 77 (64.2%).
The people had the Brazilian Health Public System 
as the funding source of treatment, represented by 
110 (91.6%) and only 10 (8.33%) had private health 
plans. 
The average age was 53.77±17.7 years old, ran-
ging between 13 and 92, had greater prevalence 
between the fifth and sixth decades of life.
The average time on Renal Replacement Therapy 
(RRT) was 22.46±21.42 mounts or 1.87±1.78 year, 
96 (80) patients were less than three years and 
there aren’t patients with more than 10 years in 
treatment.
Table 1:  Distribution of patients according of the 
sample composition from CNJ, Juazeiro do 
Norte, CE, Brazil, January 2013.
Demographic characteristics n(120) % (100)
Sex
Male 77 64.2
Female 43 35.8
Age
≤20 years 03 2.5
21-40 26 21.7
41-60 48 40.0
61-80 35 28.2
≥ 81 years 08 6.7
Dialysis time
Less than 1 ano 44 36.7
≥ 1 e <3 years 52 43.3
≥ 3 e <5 years 15 12.5
≥ 5 e <10 years 09 7.5
> 10 years 00 0.0
The most common End Stage Renal Disease (ESRD) 
etiology was unknown cause, affecting 38 (31.7%) 
patients, diabetic nephropathy was the most speci-
fic cause found with 31 (25.8%) patients and hyper-
tension, 10 (8.3%). Remember that is not accounted 
number of hypertensive patients, but numbers of 
patients with Nephrosclerosis Hypertensive causing 
the ESRD condition.
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Table 2:  Cause Chronic Kidney Disease patients from 
CNJ, Juazeiro do Norte, CE, january 2013.
n (120) % (100)
Cause Chronic 
Kidney Disease
Unspecified 38 31.7
Diabetes Mellitus 31 25.8
Hypertension 10 8.3
Policystic Kidney 05 4.2
Glomerulonephritis 13 10.8
Prolonged IRA 06 5.0
Others 17 14.2
Regarding access to dialysis, 93 (77.5%) had un-
dergone creating an AVF, and only 89 (74.1%) were 
suitable for use, or were undergoing haemodialysis 
through an AVF and four were in the process of 
maturation. Among the 93 patients who had fistu-
las, two (1.7%) was prepared by a synthetic mate-
rial such as polytetrafluoroethylene (PTFE). Catheter 
were undergoing how haemodialysis via central ve-
nous access in 27 (22.5%) patients. Among the 27 
patients using central venous catheter, seven were 
long-term and the short-term were 10. The average 
time in use of fistulas was 1.61±1.64 years, ranging 
from 2 months to 8 years and the implanted cathe-
ters, 3.2±6.9 months for short-term and 5.2±5.4 for 
long-term catheter. 
Table 3:  Number of vascular access made for patient 
from CNJ, Juazeiro do Norte, CE, january 
2013.
 n (120) %(100)
Number of 
fistulas made/
patient
None 16 13.3
01 60 50.0
02 28 23.3
03 10 8.3
04 06 5.0
Number 
of cateter 
implanted/
patient
None 02 1.7
01 60 50.0
02 24 20.0
03-04 13 10.8
05-06 11 9.2
06-07 08 5.8
09 or more 03 2.5
Considering the arteriovenous fistulas, 59 (63.5%) 
were located in the left arm and 37 (39.8%) were 
radiocephalic, 17 (18.3%) were brachiocephalic, 5 
(5.4%) were Brachiobasilic; 34 (36.6%) were located 
in the right arm and 23 (24.7%) were radiocephalic, 
9 (9.7%) were brachiocephalic, 2 (2.2%) were bra-
chiobasilic. Fifty percent of the fistulas were distal.
Considering the mean number of catheters used 
by patients, there was an average of 2.51±2.43 
catheters per patient, and an average of 1.41±0.99 
fistulas per patient.
Considering the sites of puncture catheter, 16 
(59.3%) were implanted in the right jugular vein, 5 
(18.5%) in the right femoral vein, 3 (11.1%) in right 
subclavian; 1 (3.7%) in left subclavian, jugular and 
femoral vein.
If we consider the patency time of the last used 
access, we found 1.32±1.56 years; for fistulas, 
1.61±1.64 and 0.31±0:54 for all catheters.
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Table 4:  Distribution of vascular access in use on 
CNJ. Juazeiro do Norte, CE, january 2013.
Vascular access n (120) % (100)
Initial access 
for dialysis
Central Vein Catheter (CVC) 118 98.3
Arteriovenous fistula 02 1.7
Peritoneal cateter 00 0.0
Vascular 
acess in use
Native 91 75.8
PTFE 02 1.7
CVC long-term 07 5.8
CVC short-term 20 16.7
Location of 
arteriovenous
fistula
Right radiocephalic 23 24.7
Left radiocephalic 37 39.8
Right brachiocephalic 09 9.7
Left brachiocephalic 17 18.3
Right Brachiobasilic 02 2.2
Left brachiobasilic 05 5.4
Sites of 
puncture 
catheter in 
use
Vein jugular - right 16 59.3
Vein jugular – left 01 3.7
Vein femoral – right 05 18.5
Vein femoral – left 01 3.7
Vein subclavia – right 03 11.1
Vein subclavia - left 01 3.7
Discussion
The NKF-DOQI created in 1997 guidelines for stan-
dardization of care for renal disease to dialysis in 
relation to vascular access in order to decrease the 
complications and cost, improve the dialysis quality. 
The improvement of the patients quality of life can 
be reported lower number of use and complications 
of vascular access for haemodialysis due to catheter 
use and fistula with prosthesis. [18].
The periodic review of access for haemodialysis is 
intended to be performed on all services in order to 
monitor their adequacy in relation to international 
guidelines. According to these premises, we perfor-
med at the Juazeiro Nephrology Center as investiga-
tion which aims to verify the adequacy and monitor 
the vascular access, within the standards established 
by the guidelines [1, 19-21].
The most patients had less than three years on 
dialysis; the fact could be a consequence of the 
short time of opening of the dialysis unit.
According to the latest Brazilian Census of Dialy-
sis, 2012, 84% of patients had the health public 
system funding source, this shows that it is the main 
financier. In our study, we found that treatment of 
91.7% of patients were funded by the SUS – Sis-
tema Único de Saúde and is above the national 
average possibly by lower purchasing power of the 
local population when compared to the Brazilian 
population. In further, accordance with the data of 
Brazilian Nephrology Society, we found dissonant, 
57.7% of the patients were female compared with 
35.8% of our sample. [22].
As the distribution of patients according to age 
group, most patients were aged below 64 years, 
consistent with data from the Sense of Brazilian Ne-
phrology Society - SBN [22].
We found that the main cause leading to ESRD 
was of unknown origin and represented 31.7%, 
followed by 25.8% of Diabetes and Hypertension 
occurred in 8.3%; finding different census indicated 
that the SBN as first cause Hypertension (33.8%), 
followed by diabetes (28.5%), chronic glomerulo-
nephritis (12.6%) and undetermined origin (9.5%). 
A significant proportion of patients with unknown 
etiology are reported in the literature, 16.2% of the 
elderly Indian Affairs, [12] 5.9% in the United States, 
18% in the United Kingdom [13] and, similarly, 14, 
8% in Iran. [14] Our finding of 31.7% of cases of 
unknown etiology may reflect the lack of awareness 
of the disease, deficiency in early diagnosis and de-
lay in referral before you get to the specialist. [23].
According to our results, the percentage of pa-
tients on dialysis with arteriovenous fistulas was 
higher than recommended by NKF - DOQI 2006 
(70%) and represented 77% of vascular access. 
However, in the national census data represented 
85.5% of accesses. Our data could still not the 
best if not consider that 12.5% of patients had 
less than three months on haemodialysis. During 
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this time, they might improve renal function, no 
needed of fistula and our percentage would in-
crease to 88.6% without considering them. This 
dialysis service attends many patients diagnosed 
with Acute Renal Failure and this finding can mix 
up the results.
Furthermore, the location of leaks is in accordan-
ce with international guidelines. We have reported 
prevalence radiocephalic localization (64.5%), which 
has a high rate in primary fistula. It is an ideal com-
bination to the patient because it is associated with 
a lower rate of complications and, therefore, impro-
ving the quality of life [18, 24, 25]. We still showed 
that 50% of patients underwent a single prepara-
tion of fistula. The access should be placed distally 
and in the upper extremities whenever possible. It’s 
preferred primary radiocephalic fistula, an elbow 
(brachiocephalic) primary fistula, to a transposed 
brachial basilic, vein fistula [10]. 
The preferred insertion site for tunneled cuffed 
venous dialysis catheters or port catheter systems 
is the right internal jugular vein. Subclavian access 
should be used only when no other upper-extremity 
or chest-wall options are available. In our study, the-
re was a predilection to implant catheters in the 
jugular veins, especially the right as the main gui-
delines recommend and it was represented to 63% 
of all catheters. [10].
An intriguing finding was that 14.8% of patients 
were catheterized in subclavian veins. Subclavian 
vein catheterization is associated with central ve-
nous stenosis [26-28]. Significant subclavian vein 
stenosis generally will preclude the use of the en-
tire ipsilateral arm for vascular access. Thus, sub-
clavian vein catheterization should be avoided for 
temporary access in patients with kidney disease. 
[10] All these catheters were implanted in the lar-
gest hospital in the region. Therefore, this finding 
mischaracterizes the actual statistics of the haemo-
dialysis service.
Conclusion
The KDOQI was designed to improve patient outco-
me by investigating hemodialysis patients. The re-
sults of this study in patients selected from Juazeiro 
Nephrology Center suggest that patient characteris-
tics and treatment patterns are same the goals of 
Current Guidelines.
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